African Iboga Root Heads To Canadian Company Developing Natural Drugs To Help Treat Addictions
Clinical-stage natural psychedelics company Filament Health Corp. (OTCQB: FLHLF) has completed the first-ever Nagoya Protocol-compliant import of Tabernanthe iboga root from Gabon to the company’s R&D Vancouver facility.
